49.05
-0.03
(-0.05%)
At close: 3:33:12 PM GMT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 5 | 10 | 10 |
Avg. Estimate | 22.77B | 22.53B | 86.27B | 88.55B |
Low Estimate | 21.6B | 21.19B | 84.02B | 83.46B |
High Estimate | 25.24B | 25.27B | 89.27B | 102.25B |
Year Ago Sales | 22.98B | 21.85B | 93.94B | 86.27B |
Sales Growth (year/est) | -0.91% | 3.13% | -8.15% | 2.64% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ADMD.XC | -- | -- | -- | -- |
S&P 500 | 8.39% | 11.26% | 13.82% | 13.53% |
Upgrades & Downgrades
Downgrade | B of A Securities: Neutral to Underperform | 1/14/2025 |
Maintains | Citigroup: Neutral to Neutral | 12/4/2024 |
Maintains | BMO Capital: Market Perform to Market Perform | 12/4/2024 |
Maintains | Barclays: Underweight to Underweight | 12/4/2024 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/12/2024 |
Maintains | UBS: Neutral to Neutral | 9/9/2024 |